Envista Holdings Corp (STU:0HV)
€ 21 0 (0%) Market Cap: 3.63 Bil Enterprise Value: 4.18 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 73/100

Envista Holdings Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 09:30PM GMT
Release Date Price: €28.8 (+1.41%)
Casey Rene Woodring
JPMorgan Chase & Co, Research Division - Research Analyst

Hi, everyone. Welcome to the 2021 JPMorgan Healthcare Conference. My name is Casey Woodring, and I'm a member of the Life Science Group and Diagnostics Equity Research team here at JPMorgan.

Today, it's my pleasure to introduce the management team of Envista. (Operator Instructions) And with that, let me turn it over to Amir.

Amir Aghdaei
Envista Holdings Corporation - President, CEO & Director

Thank you, Casey. Thanks for having us. I'm going to refer to specific pages in here to get us started. I'll give you a little bit of a view of Envista on Page 3. We're about $2.8 billion based on 2019 revenue. This is all come off 28 acquisition as part of Danaher. We've been independent and publicly traded since September of 2019. About 55% gross margin, mid-teens EBITDA based on 2019.

It's commission of a large number of brands. Brands have been around for a long period of time and have tremendous amount of industry experience and knowledge. We're really like

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot